It was a pleasure to catch up with our Editorial Board member, Prof. Anat Loewenstein (Tel Aviv Medical Center, Israel), who talked to us about the importance of home monitoring in wet age-related macular degeneration.
- How has the COVID-19 pandemic affected the management of patients with wet age-related macular degeneration (AMD)? (0:10)
- How can home monitoring of visual changes improve the monitoring of wet AMD? (02:36)
- Could you tell us a little about home optical coherence tomography (OCT) technology and its ease of use in elderly populations? (03:36)
- Could you give us an overview of the study of home OCT that you are leading? (04:37)
- What other promising remote monitoring systems are emerging? (05:40)
Speaker Disclosure: Prof. Anat Loewenstein discloses the following: consultant for: Allergan, Bayer, Novartis, Notal – vision, Syneos health, beyeonics surgical, Roche, Pres-By, Xbran, WebMD, KHB, Oxurion.
Support: Interview and filming supported by Touch Medical Media Ltd.
Filmed in coverage of EURETINA 2020.
Share this Video
Related Videos In Macular Degeneration
Usha Chakravarthy, EURETINA 2022: Persistent fluid in neovascular age-related macular degeneration
The Archway study (NCT03677934) was a phase 3, randomized, active treatment–controlled trial for the treatment of nAMD, conducted at 77 study locations in the United States. We caught up with Prof. Usha Chakravarthy (Queen’s University of Belfast, Belfast, Northern Ireland) to discuss the causes of persistent fluid in neovascular age-related macular degeneration and the impact […]
Anat Loewenstein, EURETINA 2022: Home Monitoring for Age-related Macular Degeneration
It was a pleasure to interview Prof. Anat Loewenstein (Tel Aviv Medical Center, Tel Aviv, Israel) on her EURETINA presentation discussing the advantages of home monitoring of age-related macular degeneration, and the results of a study evaluating a new device for home monitoring. The abstract ‘Functional and anatomical options for home monitoring in the era […]
Katerina Prokopiou, ARVO 2022: Therapeutic potential of omega-3 fatty acids supplementation in dry age-related macular degeneration and Stargardt Disease
The clinical outcomes of the MADEOS trial (NCT03297515) is discussed in this touchOPHTHALMOLOGY interview with Dr Katerina Prokopiou (University of Nicosia Medical School, Engomi, Cyprus). Currently, there is no effective treatment available that stops progression or improves vision in patients with dry age-related macular degeneration or Stargardt disease, the MADEOS trial assesses the therapeutic potential of […]
Journal articles and more to your inbox
Get the latest clinical insights from touchOPHTHALMOLOGYSign me up!